Bill Schiffner
Sephora, Dove top CPG 2024’s Most Innovative Brands List
NEW YORK – CPG brands outpaced Technology nearly 2:1 in the 2024 Most Innovative Brands survey conducted by Brand Keys, Inc. (www.brandkeys.com), the New York-based brand loyalty and engagement research firm.
NRF unveils 2024 Top 50 Global Retailers
WASHINGTON – The National Retail Federation today announced the 2024 Top 50 Global Retailers. Conducted by Kantar, the 2024 list ranks international retailers, based on their operational performance as of the beginning of 2023.
99 Cents Only Stores is going out of business
The value retailer 99 Cents Only Stores LLC commenced going-out-of-business sales at all of its locations on Friday, as part of a plan to wind down its operations and close all its stores. The liquidation sale will include all 371 of the retailer’s stores, which are located in Arizona, California,
Dramamine celebrates 75 years of the barf bag
1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine.
P&G recalls 8.2 million defective bags of Tide, Gain, Ace and Ariel laundry detergent packets
Procter & Gamble today announced a voluntary packaging recall of Tide Pods, Gain Flings, Ace Pods and Ariel Pods liquid laundry detergent packets packaged in flexible film bags. This recall announcement applies only to bags distributed in the United States.
Albertsons Cos. debuts simplified loyalty program
Albertsons Cos. has launched a new, simpler version of its “for U” loyalty program, designed to provide more value and greater ease for the retailer’s 38 million loyalty program members.
PCMA releases statement on CMS Part D biosimilar substitution announcement
The Pharmaceutical Care Management Association (PCMA) released the following statement on the recent announcement from the Centers for Medicare and Medicaid Services (CMS) to allow Medicare Part D plans to substitute all FDA-approved biosimilars on their formularies.
CRN files preliminary injunction motion seeking to stop NY state age-restriction law
The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, announced today that it has filed an emergency motion seeking to prevent enforcement by the New York State Attorney General of a new law passed in 2023 that will age re
Indeed Labs now in CVS Stores nationwide
Canadian skincare brand Indeed Labs has officially expanded their retail presence in the U.S. by launching 6 of their viral products in 2,700 CVS stores nationwide. Products available in CVS include award-winning Nanoblur Instant Skin-Blurring Cream ($24.
New generative AI application from Zebra Technologies and Google Cloud
LINCOLNSHIRE, Ill. – Zebra Technologies Corporation announced its collaboration with Google Cloud, Android, and Qualcomm Technologies, Inc. to help enterprises deliver transformative customer experiences along with improved employee productivity and insights powered by generative AI.
Rite Aid announces availability of Opill at all locations
Rite Aid Corporation announced on Thursday that the Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores.
NACDS hails enactment of Idaho PBM Reform Bill
signed on April 1 by Governor Brad Little (R-ID) — will help reduce prescription drug prices and preserve Idahoans’ access to pharmacies and pharmacy services. HB 596 includes important PBM reforms
CHPA responds to FDA draft guidance on NDIN master files for dietary supplements
(WASHINGTON, D.C.) – The Consumer Healthcare Products Association released the following statement today in response to draft guidance released from the U.S.
VeriSIM Life announces the launch of AtlasGEN Novel Drug Designer
SAN FRANCISCO – VeriSIM Life, the leading AI-enabled R&D de-risker for breakthrough drug design and development, announced today the availability of AtlasGEN™ Novel Drug Designer.
CRN comments on FDA NDI guidance
In regard to FDA issuing draft guidance on NDI notification master files for supplements today, CRN president and CEO Steve Mister offered the following comments on the development: “It’s a positive development to see the FDA moving ahead with this draft guidance.